Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Fluindione

Alternative Names: fluindione
Latest Update: 2024-12-17
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Vitamin K Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: France | Luxembourg

Approved Indications: None

Known Adverse Events: None

Company: Daiichi Sankyo
Company Location: TOKYO M0 103-8426
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Atrial Fibrillation|Kidney Diseases|Venous Thrombosis|Pulmonary Embolism|Blood Coagulation Disorders|Calcinosis|Embolism and Thrombosis|Vascular Calcification|Hemostatic Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
PHRC-N/2020/BL-01

P3

Unknown Status

Unknown

2026-11-30

AVKDIAL

P4

Terminated

Atrial Fibrillation|Kidney Diseases

2023-08-10

HEMA-HTP

N/A

Completed

Hypertension, Pulmonary

2022-09-13

PRESAGE-ACO

N/A

Completed

Atrial Fibrillation

2021-11-01

Recent News Events

Date

Type

Title

12/12/2023

PubMed

 Calciphylaxis, beware the ophthalmic mimic: A case series.

08/01/2023

PubMed

 Quantitative determination of plasma free and total concentrations of antivitamin K drugs using a new sensitive and rapid LC-MS/MS method: Application in hemodialysis patients.

05/29/2023

PubMed

 Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

12/16/2020

News Article

 Global Clinical Chemistry Database for the US, Europe & Japan (2020 to 2025) - Analyzers and Reagents for 100 Tests, Supplier Shares, Volume and Sales Segment Forecasts - ResearchAndMarkets.com

08/05/2020

News Article

 Fluindione (CAS 957-56-2) Market Research Report 2020 - ResearchAndMarkets.com

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions